Login / Signup

Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment.

Nam Hee KimYong Kyun ChoByung Ik KimHong Joo Kim
Published in: Digestive diseases and sciences (2018)
MS is an independent determinant of poor prognosis in CHB patients receiving oral NUCs treatment.
Keyphrases
  • poor prognosis
  • metabolic syndrome
  • long non coding rna
  • hepatitis b virus
  • mass spectrometry
  • multiple sclerosis
  • type diabetes
  • ms ms
  • molecular docking
  • molecular dynamics simulations
  • replacement therapy